Evaluation of a New DNA Test for Detection of Carcinogenic Human Papillomavirus

被引:26
作者
Castle, Philip E. [1 ]
Gutierrez, Erin C. [2 ]
Leitch, Sharon V. [2 ]
Maus, Courtney E. [2 ]
McMillian, Ray A. [2 ]
Nussbaumer, William A. [2 ]
Vaughan, Laurence M. [2 ]
Wheeler, Cosette M. [3 ]
Gravitt, Patti E. [4 ,5 ]
Schiffman, Mark [6 ]
机构
[1] Amer Soc Clin Pathol Inst, Washington, DC 20005 USA
[2] BD Diagnost, Sparks, MD 21152 USA
[3] Univ New Mexico, Hlth Sci Ctr, Sch Med, Dept Pathol, Albuquerque, NM 87131 USA
[4] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD 21205 USA
[5] Johns Hopkins Univ, Dept Mol Microbiol & Immunol, Baltimore, MD 21205 USA
[6] NCI, Div Canc Epidemiol & Genet, NIH, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
ATYPICAL SQUAMOUS-CELLS; RANDOMIZED-TRIAL; UNDETERMINED SIGNIFICANCE; CYTOLOGY INTERPRETATIONS; CERVICAL PRECANCER; MANAGEMENT; CANCER; WOMEN; PAPANICOLAOU; BETHESDA;
D O I
10.1128/JCM.00422-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Using archived specimens, we evaluated a new automated real-time PCR assay (BD Diagnostics) that detects all carcinogenic human papillomaviruses (HPV) and provides HPV genotyping for seven of them, including HPV16 and HPV18, the two most carcinogenic HPV genotypes. We found comparable results with Hybrid Capture 2 (HC2) for detection of carcinogenic HPV (n = 473) and with Linear Array and Line Blot Assay (n = 371) for detection of individual HPV genotypes.
引用
收藏
页码:3029 / 3032
页数:4
相关论文
共 18 条
[1]   Human papillomavirus genotype specificity of Hybrid Capture 2 [J].
Castle, Philip E. ;
Solomon, Diane ;
Wheeler, Cosette M. ;
Gravitt, Patti E. ;
Wacholder, Sholom ;
Schiffman, Mark .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (08) :2595-2604
[2]   Comparison of linear array and line blot assay for detection of human papillomavirus and diagnosis of cervical precancer and cancer in the atypical squamous cell of undetermined significance and low-grade squamous intraepithelial lesion triage study [J].
Castle, Philip E. ;
Gravitt, Patti E. ;
Solomon, Diane ;
Wheeler, Cosette M. ;
Schiffman, Mark .
JOURNAL OF CLINICAL MICROBIOLOGY, 2008, 46 (01) :109-117
[3]   Process Evaluation of a Fully Automated Molecular Diagnostics System [J].
Felder, Robin A. ;
Foster, Maria L. ;
Lizzi, Michael J. ;
Pohl, Brent R. ;
Diemert, Dustin M. ;
Towns, Bryan G. .
JALA, 2009, 14 (05) :262-268
[4]  
Gravitt PE, 2000, J CLIN MICROBIOL, V38, P357
[5]   The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice [J].
Khan, MJ ;
Castle, PE ;
Lorincz, AT ;
Wacholder, S ;
Sherman, M ;
Scott, DR ;
Rush, BB ;
Glass, AG ;
Shiffman, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (14) :1072-1079
[6]  
Koutsky LA, 2000, J NATL CANCER I, V92, P397, DOI 10.1093/jnci/92.5.397
[7]  
KURMAN RJ, 1991, OBSTET GYNECOL, V77, P779
[8]   Guidelines for human papillomavirus DNA test requirements for primary cervical cancer screening in women 30 years and older [J].
Meijer, Chris J. L. M. ;
Berkhof, Johannes ;
Castle, Philip E. ;
Hesselink, Albertus T. ;
Franco, Eduardo L. ;
Ronco, Guglielmo ;
Arbyn, Marc ;
Bosch, F. Xavier ;
Cuzick, Jack ;
Dillner, Joakim ;
Heideman, Danielle A. M. ;
Snijders, Peter J. F. .
INTERNATIONAL JOURNAL OF CANCER, 2009, 124 (03) :516-520
[9]   Determinants of genital human papillomavirus detection in a US population [J].
Peyton, CL ;
Gravitt, PE ;
Hunt, WC ;
Hundley, RS ;
Zhao, MF ;
Apple, RJ ;
Wheeler, CM .
JOURNAL OF INFECTIOUS DISEASES, 2001, 183 (11) :1554-1564
[10]   American Cancer Society guideline for the early detection of cervical neoplasia and cancer [J].
Saslow, D ;
Runowicz, CD ;
Solomon, D ;
Moscicki, AB ;
Smith, RA ;
Eyre, HJ ;
Cohen, C .
CA-A CANCER JOURNAL FOR CLINICIANS, 2002, 52 (06) :342-362